Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +41.72%
#3 Glidr Glidr +35.94%
#4 Walrus Walrus +22.36%
#5 Tutorial Tutorial +21.99%
#6 Humanity Humanity +18.29%
#7 Codatta Codatta +15.82%
#8 Ribbita by Virtuals Ribbita by Virtuals +14.49%
#9 Cysic Cysic +14.17%
#10 Enso Enso +14.10%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
VitaSpring Biomedical Co. Ltd. VitaSpring Biomedical Co. Ltd.

VitaSpring Biomedical Co. Ltd.

VSBC
Clasificación en acciones #36819
VitaSpring Biomedical Co. Ltd. specializes in pioneering pharmaceutical... VitaSpring Biomedical Co. Ltd. specializes in pioneering pharmaceutical solutions derived from cellular medicine. It previously operated as Shemn Corp. before rebranding as VitaSpring Biomedical Co. Ltd. in February 2020. The company was established in 2016 and its main operations are based in Irvine, California.
Precio por acción
$0.0111
Última sincronización: 2026-08-13
Capitalización bursátil
$2.30M
Cambio (1 día)
0.00%
Cambio (1 año)
-98.89%
País
US
Comercio VitaSpring Biomedical Co. Ltd. (VSBC)

Categoría

Healthcare
Ganancias de VitaSpring Biomedical Co. Ltd. (VSBC)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di VitaSpring Biomedical Co. Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de VitaSpring Biomedical Co. Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE